Humana
About: Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Employees: 65,680
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 9 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
3.79% more ownership
Funds ownership: 92.45% [Q3] → 96.24% (+3.79%) [Q4]
8% more call options, than puts
Call options by funds: $1.86B | Put options by funds: $1.73B
7% less funds holding
Funds holding: 923 [Q3] → 859 (-64) [Q4]
14% less funds holding in top 10
Funds holding in top 10: 14 [Q3] → 12 (-2) [Q4]
15% less capital invested
Capital invested by funds: $34.9B [Q3] → $29.8B (-$5.16B) [Q4]
24% less first-time investments, than exits
New positions opened: 143 | Existing positions closed: 187
26% less repeat investments, than reductions
Existing positions increased: 269 | Existing positions reduced: 365
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$256
2%
downside
Avg. target
$300
15%
upside
High target
$326
24%
upside
9 analyst ratings
3 positive
33%
6 neutral
67%
0 negative
0%
Baird Michael Ha 43% 1-year accuracy 10 / 23 met price target | 14%upside $300 | Neutral Maintained | 15 Apr 2025 |
Barclays Andrew Mok 35% 1-year accuracy 21 / 60 met price target | 23%upside $322 | Equal-Weight Maintained | 11 Apr 2025 |
Truist Securities David Macdonald 53% 1-year accuracy 54 / 101 met price target | 24%upside $325 | Hold Maintained | 11 Apr 2025 |
Guggenheim Jason Cassorla 21% 1-year accuracy 3 / 14 met price target | 24%upside $326 | Buy Initiated | 9 Apr 2025 |
Mizuho Ann Hynes 48% 1-year accuracy 10 / 21 met price target | 21%upside $316 | Outperform Maintained | 9 Apr 2025 |
Financial journalist opinion
Based on 35 articles about HUM published over the past 30 days
Positive
Zacks Investment Research
1 hour ago
Humana's Q1 Earnings Beat Estimates on CenterWell Segment Strength
HUM's first-quarter results reflect higher primary care revenues and a well-performing Medicare stand-alone PDP business, partly offset by elevated operating costs.
Positive
Zacks Investment Research
3 hours ago
CNC vs. HUM: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - HMOs sector have probably already heard of Centene (CNC) and Humana (HUM). But which of these two stocks presents investors with the better value opportunity right now?
Positive
Investopedia
5 hours ago
Humana Cost Cuts, Medicare Advantage Moves Boost Results
Humana (HUM) shares edged higher when the health insurer reported better-than-expected results as it lowered costs and pulled out of certain Medicare Advantage plans.
Neutral
Zacks Investment Research
5 hours ago
Humana (HUM) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Neutral
Seeking Alpha
6 hours ago
Humana, Inc. (HUM) Q1 2025 Earnings Call Transcript
Humana, Inc. (NYSE:HUM ) Q1 2025 - Earnings Conference Call April 30, 2025 8:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Renaudin - President, Insurance Conference Call Participants Sarah James - Cantor Fitzgerald Ben Hendrix - RBC Capital Markets Justin Lake - Wolfe Research Andrew Mok - Barclays Stephen Baxter - Wells Fargo AJ Rice - UBS Joshua Raskin - Nephron Research Joanna Gajuk - Bank of America Lance Wilkes - Bernstein Erin Wright - Morgan Stanley Lisa Gill - JPMorgan Michael Hall - Baird David Windley - Jefferies George Hill - Deutsche Bank Anne Hines - Mizuho Operator Good day, and thank you for standing by. Welcome to Humana's First Quarter 2025 Earnings Call.
Positive
Market Watch
7 hours ago
Humana's exit of some ‘unprofitable' Medicare plans helps fuel a big profit beat
While Humana affirmed its full-year profit outlook, which can be viewed as a positive in the current uncertain economic environment, quarterly revenue came up a bit shy, and the earnings outlook for the current quarter was below Wall Street projections.
Positive
Zacks Investment Research
8 hours ago
Humana (HUM) Q1 Earnings Surpass Estimates
Humana (HUM) came out with quarterly earnings of $11.58 per share, beating the Zacks Consensus Estimate of $9.98 per share. This compares to earnings of $7.23 per share a year ago.
Positive
Reuters
10 hours ago
Humana beats first-quarter profit estimates on lower costs
Humana beat Wall Street estimates for first-quarter profit on Wednesday, as the health insurer spent less on medical services than expected.
Neutral
Business Wire
10 hours ago
Humana Reports First Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted Financial Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2025 (1Q25) versus the quarter ended March 31, 2024 (1Q24) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 1Q25 (a) 1Q24 (a) Generally Accepted Accounting Principles (GAAP) $1,691 $1,014 Amortization associated with identifiable intangibles 15 16 Put/call v.
Negative
Barrons
1 day ago
Humana Earnings Are Up Next. The Stock's Struggles Continue.
Humana HUM -1.46% stock seems to have slowed its multi-year slide, but its valuation still lies in the doldrums. When the company reports earnings Wednesday morning, investors likely won't focus on the past quarter's performance, but on the forecast for returning the former Wall Street darling to earnings growth.
Charts implemented using Lightweight Charts™